What is cromolyn (cromolyn sodium)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Cromolyn Sodium?

Cromolyn sodium (also called disodium cromoglycate) is a mast cell stabilizer medication used as a preventive, anti-inflammatory treatment for asthma—it works by blocking the release of inflammatory mediators from mast cells in the airways, thereby preventing asthma attacks before they occur. 1, 2

Mechanism of Action

Cromolyn sodium functions by:

  • Stabilizing mast cells in the airway lining, preventing them from releasing inflammatory chemicals (mediators) that trigger asthma attacks 2
  • Interfering with chloride channel function in these cells 1
  • Blocking both early and late asthmatic responses induced by allergen exposure and exercise 3
  • Potentially reducing bronchial hyperreactivity over time 3

The key distinction is that cromolyn prevents attacks rather than relieves them once they start—it has no bronchodilator properties and cannot reverse active bronchospasm 2, 4.

Clinical Role in Asthma Management

Current Position in Treatment Guidelines

Cromolyn is classified as an alternative (but not preferred) long-term control medication for mild persistent asthma 1. The hierarchy is clear:

  • Preferred therapy: Inhaled corticosteroids (ICS) at all steps of persistent asthma 5, 1
  • Alternative options: Cromolyn, leukotriene receptor antagonists (LTRAs), or nedocromil 5, 1

This recommendation reflects evidence showing that while cromolyn provides symptom control superior to placebo, inhaled corticosteroids are significantly more effective in improving lung function, reducing exacerbations, and controlling asthma symptoms 5.

Specific Clinical Uses

Cromolyn can be used in two ways:

  1. Regular prophylactic therapy: Taken 4 times daily on a continuous basis to maintain asthma control 2
  2. Pre-exposure prevention: Taken 10-15 minutes before exercise or unavoidable allergen exposure to prevent exercise-induced bronchospasm 1, 5, 1, 2

Age-Specific Considerations

  • Children ≥5 years: Alternative therapy for mild persistent asthma (Step 2 care) 5, 1
  • Children <5 years: Alternative option alongside LTRAs when oral therapy is preferred over inhaled corticosteroids 5
  • All ages: Can be considered when patient circumstances make ICS administration difficult 5

Important Clinical Characteristics

Time to Effectiveness

  • Cromolyn starts working immediately but requires 2 weeks to 1 month of regular use to bring asthma under full control due to pre-existing airway inflammation 2
  • Must be taken regularly even when asymptomatic 2

Safety Profile

Cromolyn has an exceptionally strong safety record—it remains unique among asthma medications for its extensive clinical history with minimal adverse effects 6, 7, 3. Adverse reactions are uncommon to rare, typically mild, short-lived, and without long-term consequences 7.

Formulations

Available as:

  • Nebulizer solution (20 mg per 2 mL vial) 2
  • Metered-dose inhaler (MDI) 6
  • Requires power-driven nebulizer at 6-8 liters/minute airflow; hand-operated nebulizers are inadequate 2

Critical Limitations

Why Cromolyn is Not Preferred

The evidence is unequivocal: systematic reviews found insufficient evidence that cromolyn provides meaningful benefit in maintenance treatment of childhood asthma 5. While nedocromil (a similar mast cell stabilizer) reduces urgent care visits and prednisone requirements compared to placebo, it shows no difference on other outcome measures and is significantly less effective than inhaled corticosteroids 5.

Not for Acute Relief

Cromolyn cannot relieve an active asthma attack—patients need a bronchodilator (short-acting beta-agonist) for acute symptoms 2. It is purely preventive.

Practical Prescribing Considerations

When initiating cromolyn:

  • Continue other asthma medications until advised otherwise by physician 2
  • May need concurrent bronchodilator for breakthrough symptoms 2
  • Monitor response with symptom diary and peak flow measurements 2
  • If no clear benefit within 4-6 weeks with good adherence and technique, consider alternative therapies 8
  • Attempt step-down after 3 months of good control 8

Storage: Keep at room temperature (68-77°F), protect from light, discard if solution contains precipitate or becomes discolored 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.